Rivera J, Cano A
Department of Obstetrics and Gynaecology, Facultad de Medicina, Universidad de Valencia, Spain.
Placenta. 1989 Nov-Dec;10(6):579-88. doi: 10.1016/0143-4004(89)90049-0.
Oestrogen and progesterone receptors have been implicated in human placental steroidogenesis, but studies developed to measure their concentration in this tissue at term yielded discrepant results. Potential inaccuracy of the binding assays, the technique used in previous studies, might influence the discrepancy. In the present study, oestrogen and progesterone receptors were investigated by two different approaches: binding assays with radiolabelled ligand and immunoassays with monoclonal antibodies against receptors. Binding assays included techniques to quantify free and occupied sites in both the cytosolic and nuclear fraction. Conditions intended to block or decrease potential causes of inaccuracy, such as proteolysis or thermal denaturation of the sites, were included in the assays. Cytosolic specific binding was measured by two different techniques, dextran-coated charcoal and hydroxylapatite, whereas nuclear sites were studied on salt-extracts and by exchange. Negative or moderately positive results were obtained for either oestrogen or progesterone receptors, but high levels of non-specific binding made the technique unreliable. Immunoassays included the use of two techniques, histochemistry and enzyme-linked-immunosorbent-assay (ELISA). Both frozen and paraffin (Bouin solution or buffered formalin as fixatives) sections were stained with monoclonal antibodies against the oestrogen receptor. Results were always negative in all cases. Levels of oestrogen and progesterone receptors were measured in either cytosol or nuclear extracts by ELISA. This technique was highly sensitive and reproducible. Results were negative for both the cytosolic and nuclear fractions of oestrogen receptors. For progesterone receptors, low positivity was obtained in either crude (3.2 +/- 0.4 fmol/mg protein, mean +/- s.e.) or ammonium sulphate precipitated cytosols (12.6 +/- 3.5 fmol/mg protein, mean +/- s.e.), whereas the values for nuclear extracts were 62.0 +/- 9.0 fmol/mg DNA (mean +/- s.e.). We conclude that: (1) oestrogen receptors could not be detected in human term placenta by the methods used in this study, and (2) low levels of progesterone receptors were detected in both cytosolic and nuclear extracts.
雌激素和孕激素受体与人类胎盘类固醇生成有关,但旨在测量足月时该组织中其浓度的研究结果却不一致。先前研究中使用的结合测定技术可能存在潜在误差,这可能影响了结果的差异。在本研究中,采用两种不同方法研究雌激素和孕激素受体:用放射性标记配体的结合测定法和用抗受体单克隆抗体的免疫测定法。结合测定法包括定量胞质和核部分中游离和占据位点的技术。测定中包括旨在阻断或减少潜在误差原因(如位点的蛋白水解或热变性)的条件。通过两种不同技术(葡聚糖包被活性炭和羟基磷灰石)测量胞质特异性结合,而通过盐提取和交换研究核位点。雌激素或孕激素受体均获得阴性或中度阳性结果,但高水平的非特异性结合使该技术不可靠。免疫测定法包括使用两种技术,即组织化学和酶联免疫吸附测定法(ELISA)。用抗雌激素受体单克隆抗体对冷冻切片和石蜡切片(用Bouin溶液或缓冲福尔马林作为固定剂)进行染色。所有情况下结果均为阴性。通过ELISA测量胞质或核提取物中雌激素和孕激素受体的水平。该技术高度灵敏且可重复。雌激素受体的胞质和核部分结果均为阴性。对于孕激素受体,在粗提胞质(3.2±0.4 fmol/mg蛋白质,平均值±标准误)或硫酸铵沉淀胞质(12.6±3.5 fmol/mg蛋白质,平均值±标准误)中获得低阳性结果,而核提取物的值为62.0±9.0 fmol/mg DNA(平均值±标准误)。我们得出结论:(1)通过本研究中使用的方法在人类足月胎盘中未检测到雌激素受体,(2)在胞质和核提取物中均检测到低水平的孕激素受体。